Hartford Investment Management CO Biogen Inc. Transaction History

Hartford Investment Management CO

$2.99 Billion
Q3 2024

A detailed history of Hartford Investment Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 9,132 shares of BIIB stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,132

Previous 9,308 1.89%

Holding current value

$1.44 Million

Previous $2.16 Million 17.94%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$189.07 - $236.8 $33,276 - $41,676	-176 Reduced 1.89%	9,132 $1.77 Million
Q2 2024 Aug 01, 2024	SELL	$190.52 - $236.72 $8,954 - $11,125	-47 Reduced 0.5%	9,308 $2.16 Million
Q1 2024 Apr 17, 2024	SELL	$212.02 - $267.71 $86,292 - $108,957	-407 Reduced 4.17%	9,355 $2.02 Million
Q4 2023 Jan 23, 2024	SELL	$222.59 - $267.94 $536,219 - $645,467	-2,409 Reduced 19.79%	9,762 $2.53 Million
Q3 2023 Oct 16, 2023	SELL	$253.3 - $285.89 $5,572 - $6,289	-22 Reduced 0.18%	12,171 $3.13 Million
Q2 2023 Jul 19, 2023	SELL	$275.25 - $318.06 $558,482 - $645,343	-2,029 Reduced 14.27%	12,193 $3.47 Million
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $1.22 Million - $1.39 Million	-4,769 Reduced 25.11%	14,222 $3.95 Million
Q4 2022 Jan 20, 2023	SELL	$252.44 - $306.72 $43,672 - $53,062	-173 Reduced 0.9%	18,991 $5.26 Million
Q3 2022 Nov 02, 2022	BUY	$194.69 - $268.46 $98,513 - $135,840	506 Added 2.71%	19,164 $5.12 Million
Q2 2022 Jul 22, 2022	BUY	$187.54 - $223.02 $32,819 - $39,028	175 Added 0.95%	18,658 $3.81 Million
Q1 2022 Apr 20, 2022	SELL	$193.77 - $244.14 $205,783 - $259,276	-1,062 Reduced 5.43%	18,483 $3.89 Million
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $224,367 - $288,345	1,002 Added 5.4%	19,545 $4.69 Million
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $550,698 - $718,171	-1,946 Reduced 9.5%	18,543 $5.25 Million
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $111,370 - $178,325	430 Added 2.14%	20,489 $7.1 Million
Q1 2021 Apr 21, 2021	SELL	$242.95 - $284.63 $86,004 - $100,759	-354 Reduced 1.73%	20,059 $5.61 Million
Q4 2020 Feb 01, 2021	BUY	$236.26 - $355.63 $548,359 - $825,417	2,321 Added 12.83%	20,413 $5 Million
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $302,896 - $349,732	-1,144 Reduced 5.95%	18,092 $5.13 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $1.05 Million - $1.39 Million	-4,062 Reduced 17.43%	19,236 $5.15 Million
Q1 2020 Apr 24, 2020	BUY	$268.85 - $341.04 $465,110 - $589,999	1,730 Added 8.02%	23,298 $7.37 Million
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $195,193 - $269,710	-887 Reduced 3.95%	21,568 $6.4 Million
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $379,867 - $426,058	-1,747 Reduced 7.22%	22,455 $5.23 Million
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $27,630 - $30,456	-126 Reduced 0.52%	24,202 $5.66 Million
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $34,890 - $54,572	-161 Reduced 0.66%	24,328 $5.75 Million
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $26,457 - $33,511	95 Added 0.39%	24,489 $7.37 Million
Q3 2018 Nov 08, 2018	SELL	$293.51 - $383.83 $62,224 - $81,371	-212 Reduced 0.86%	24,394 $8.62 Million
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $4.3 Million - $5.13 Million	-16,710 Reduced 40.44%	24,606 $7.14 Million
Q1 2018 Apr 24, 2018	SELL	$260.13 - $367.91 $897,968 - $1.27 Million	-3,452 Reduced 7.71%	41,316 $11.3 Million
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $598,975 - $670,897	-1,947 Reduced 4.17%	44,768 $14.3 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $13.1 Million - $15.4 Million	46,715	46,715 $14.6 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Biogen Inc. Transaction History